Market revenue in 2020 | USD 146.2 million |
Market revenue in 2028 | USD 387.2 million |
Growth rate | 12.9% (CAGR from 2020 to 2028) |
Largest segment | Oncology |
Fastest growing segment | Oncology |
Historical data | 2018 - 2019 |
Base year | 2020 |
Forecast period | 2021 - 2028 |
Quantitative units | Revenue in USD million |
Market segmentation | Genetic Disorders, Oncology, Personalized Medicine, Other Applications |
Key market players worldwide | Danaher Corp, Abbott Laboratories, Bio-Rad Laboratories Inc, Illumina Inc, Sysmex Corp, Roche Holding AG, BioView, MetaSystems, Agilent Technologies Inc, Revvity Inc |
No credit card required*
Name | Profile | # Employees | HQ | Website |
---|
The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to molecular cytogenetics market will help companies and investors design strategic landscapes.
Oncology was the largest segment with a revenue share of 39.33% in 2020. Horizon Databook has segmented the Japan molecular cytogenetics market based on genetic disorders, oncology, personalized medicine, other applications covering the revenue growth of each sub-segment from 2018 to 2028.
Japan is known for the most advanced technology platforms, like NGS that are available in the field of genomic medicine in the Asian countries. Regulatory guidelines set by Japan are one of the most stringent in the market and thus support development of highly efficient platforms and diagnostics.
Other factors significantly boosting market growth are rapidly ageing population and high incidence of cancers. Government research institutes along with teaching hospitals have partnered with genetic platform manufacturers to co-develop advanced platforms that comply with regulatory standards.
Furthermore, several Japanese organizations initiated various programs to support genomic research in the country, which is expected to drive the market. For instance, in April 2020, the Japan Agency for Medical Research and Development (AMED) introduced Advanced Genome Research and Bioinformatics Study to facilitate medical innovations.
Horizon Databook provides a detailed overview of country-level data and insights on the Japan molecular cytogenetics market , including forecasts for subscribers. This country databook contains high-level insights into Japan molecular cytogenetics market from 2018 to 2028, including revenue numbers, major trends, and company profiles.
Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our
free plan indefinitely.
Included in Horizon account